Literature DB >> 11310628

Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii Peninsula of Japan: clinical and neuropathological study and tau analysis.

S Kuzuhara1, Y Kokubo, R Sasaki, Y Narita, T Yabana, M Hasegawa, T Iwatsubo.   

Abstract

We report the first case of neuropathologically verified parkinsonism-dementia complex of the Kii peninsula, together with the patient's brother, who had amyotrophic lateral sclerosis. The propositus woman developed parkinsonism and dementia at 63 years of age and died at 70 without displaying clinical features of amyotrophic lateral sclerosis. The brain exhibited marked atrophy of the frontal and temporal lobes. Microscopically, there were many neurofibrillary tangles in the central nervous system, most markedly in the mesial temporal lobe and deep nuclei, as well as changes of amyotrophic lateral sclerosis but no senile plaques or Lewy bodies. Neurofibrillary tangles exhibited twisted tubule structures on electon microscopic examination, and an analysis of insoluble tau protein extracted from the fresh brain revealed a 60-, 64-, 68-kD triplet. The tau gene exhibited no mutations. Her brother developed progressive bulbar palsy-type amyotrophic lateral sclerosis at 45 years of age and died at 49 without presenting with dementia or parkinsonism. Neuropathological examination revealed not only pathologic features of amyotrophic lateral sclerosis but also a moderate number of neurofibrillary tangles in the temporal cortex and deep nuclei. The siblings were neuropathologically similar despite their different clinical manifestations. These findings suggest that amyotrophic lateral sclerosis and parkinsonism-dementia complex of this family may be phenotypic variants of a tauopathy caused by genetic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310628

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  Genetic Counseling Dilemmas for a Patient with Sporadic Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration & Parkinson's Disease.

Authors:  Vittorio Mantero; Claudia Tarlarini; Angelo Aliprandi; Giuseppe Lauria; Andrea Rigamonti; Lucia Abate; Paola Origone; Paola Mandich; Silvana Penco; Andrea Salmaggi
Journal:  J Genet Couns       Date:  2017-03-01       Impact factor: 2.537

Review 2.  A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.

Authors:  N Chernoff; D J Hill; D L Diggs; B D Faison; B M Francis; J R Lang; M M Larue; T-T Le; K A Loftin; J N Lugo; J E Schmid; W M Winnik
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017-06-09       Impact factor: 6.393

3.  C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex.

Authors:  Beth A Dombroski; Douglas R Galasko; Ignacio F Mata; Cyrus P Zabetian; Ulla-Katrina Craig; Ralph M Garruto; Kiyomitsu Oyanagi; Gerard D Schellenberg
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

Review 4.  Motor neurone disease.

Authors:  K Talbot
Journal:  Postgrad Med J       Date:  2002-09       Impact factor: 2.401

5.  The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner.

Authors:  Glen E Kisby; Rebecca C Fry; Michael R Lasarev; Theodor K Bammler; Richard P Beyer; Mona Churchwell; Daniel R Doerge; Lisiane B Meira; Valerie S Palmer; Ana-Luiza Ramos-Crawford; Xuefeng Ren; Robert C Sullivan; Terrance J Kavanagh; Leona D Samson; Helmut Zarbl; Peter S Spencer
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

6.  Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex.

Authors:  Yui Nakayama; Satoru Morimoto; Misao Yoneda; Shigeki Kuzuhara; Yasumasa Kokubo
Journal:  J Neurodegener Dis       Date:  2013-03-27

Review 7.  Risk factors for amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Per M Roos; Fredrik Piehl; Freya Kamel; Fang Fang
Journal:  Clin Epidemiol       Date:  2015-02-12       Impact factor: 4.790

Review 8.  A comprehensive review of amyotrophic lateral sclerosis.

Authors:  Sara Zarei; Karen Carr; Luz Reiley; Kelvin Diaz; Orleiquis Guerra; Pablo Fernandez Altamirano; Wilfredo Pagani; Daud Lodin; Gloria Orozco; Angel Chinea
Journal:  Surg Neurol Int       Date:  2015-11-16

9.  The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy.

Authors:  Ann C McKee; Nigel J Cairns; Dennis W Dickson; Rebecca D Folkerth; C Dirk Keene; Irene Litvan; Daniel P Perl; Thor D Stein; Jean-Paul Vonsattel; William Stewart; Yorghos Tripodis; John F Crary; Kevin F Bieniek; Kristen Dams-O'Connor; Victor E Alvarez; Wayne A Gordon
Journal:  Acta Neuropathol       Date:  2015-12-14       Impact factor: 17.088

10.  Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001-2012 survey results.

Authors:  Kiyohito Okumiya; Taizo Wada; Michiko Fujisawa; Masayuki Ishine; Eva Garcia Del Saz; Yutaka Hirata; Shigeki Kuzuhara; Yasumasa Kokubo; Harumichi Seguchi; Ryota Sakamoto; Indrajaya Manuaba; Paulina Watofa; Andreas L Rantetampang; Kozo Matsubayashi
Journal:  BMJ Open       Date:  2014-04-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.